PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WELLS FARGO & COMPANY/MN | 289 | $1,020 | 0.00% |
NORTHERN TRUST CORP | 69,595 | $245,671 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 396,396 | $1,399,277 | 0.00% |
STATE STREET CORP | 166,578 | $588,020 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 263,800 | $931,214 | 0.00% |
Tower Research Capital LLC (TRC) | 35 | $124 | 0.00% |
GOLDMAN SACHS GROUP INC | 73,914 | $260,916 | 0.00% |
MORGAN STANLEY | 323,603 | $1,142,319 | 0.00% |
WOLVERINE TRADING, LLC | 11,000 | $37,400 | 0.00% |
BlackRock Inc. | 1,517,305 | $5,356,087 | 0.00% |
Bank of New York Mellon Corp | 72,268 | $255,106 | 0.00% |
GHP Investment Advisors, Inc. | 1,170 | $4,528 | 0.00% |
MACQUARIE GROUP LTD | 61,255 | $216,000 | 0.00% |
Citadel Advisors | 16,900 | $59,657 | 0.00% |
Citadel Advisors | 11,000 | $38,830 | 0.00% |
External links
This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.